Comparison of Stabilization Exercises and Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence

Overview

The aim of the study was to compare the effects of stabilization exercises and pelvic floor muscle training in women with stress urinary incontinence.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: December 15, 2022

Detailed Description

Stress urinary incontinence is involuntary urinary incontinence with increased intraabdominal pressure. Different exercise approaches such as pelvic floor exercises and stabilization exercises are used in these patients. There is a need for studies comparing the effects of these exercises.

Interventions

  • Other: Pelvic floor exercises
    • Pelvic floor exercises for types I and II muscle fibers will be performed
  • Other: Stabilization exercises
    • Lumbar spinal stabilization exercises will be performed

Arms, Groups and Cohorts

  • Experimental: Pelvic floor exercise group
    • Pelvic floor exercises for muscle fiber types I and II will performed 3 days a week for 8 weeks
  • Active Comparator: Stabilization exercise group
    • Lumbar spinal stabilization exercises will performed 3 days a week for 8 weeks

Clinical Trial Outcome Measures

Primary Measures

  • Urinary incontinence severity
    • Time Frame: change from baseline at 8 weeks
    • Urinary incontinence severity will be measured with A 1-hour pad test

Secondary Measures

  • Urinary symptoms
    • Time Frame: change from baseline at 8 weeks
    • Urinary symptoms will be evaluated with International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
  • Life quality
    • Time Frame: change from baseline at 8 weeks
    • Life quality will be assessed with King’s Health Questionnaire.
  • Pelvic floor muscle activation response
    • Time Frame: change from baseline at 8 weeks
    • Pelvic floor muscle activation response will be measured with a portable EMG-Biofeedback device.
  • Pelvic floor muscle strength
    • Time Frame: change from baseline at 8 weeks
    • Pelvic floor muscle strength will be evaluated with Modified Oxford Scale
  • Core stability
    • Time Frame: change from baseline at 8 weeks
    • Core stability will be evaluated with Sahrmann Test using the pressure stabilizer.
  • Balance
    • Time Frame: change from baseline at 8 weeks
    • Balance will be evaluated with Biodex Balance System as static and dynamic
  • Spinal function
    • Time Frame: change from baseline at 8 weeks
    • Spinal function will be evaluated with the Spinal Mouse device in standing position.
  • Subjective perception of improvement
    • Time Frame: After treatment (at 8 week)
    • Subjective perception of improvement will be measured with a four-point Likert scale.

Participating in This Clinical Trial

Inclusion Criteria

  • Women between the ages of 18-65 who have symptoms of stress or stress-dominant mixed urinary incontinence, who volunteered to participate in the study Exclusion Criteria:

  • Those who are pregnant, have communication and cooperation problems, have a concomitant neurological or rheumatological disease, have a history of surgery involving the abdominal and pelvic regions in the last year, have undergone spine surgery, those diagnosed with pure urge urinary incontinence or mixed type incontinence, those with advanced pelvic organ prolapse, those with a spinal deformity (such as scoliosis), the presence of orthopedic problems in the lower extremities (such as lower extremity shortness, presence of deformity etc.) and vestibular system disorder

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 65 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ankara Yildirim Beyazıt University
  • Provider of Information About this Clinical Study
    • Principal Investigator: seyda toprak celenay, associate professor – Ankara Yildirim Beyazıt University
  • Overall Official(s)
    • Seyda Toprak Celenay, Principal Investigator, Ankara Yildirim Beyazıt University
  • Overall Contact(s)
    • Seyda Toprak Celenay, +90312 906 1000, sydtoprak@hotmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.